The inauguration was attended by Minister of Foreign Affairs and Trade Péter Szijjártó as well as Gedeon Richter CEO Gábor Orbán and Chairman Erik Bogsch. The new office building is a multilevel complex that includes 68 workstations, a cafeteria, a conference hall, and meeting rooms.
Headquartered in Budapest, Gedeon Richter Plc. is a multinational company, present in more than 40 countries, and responsible for producing over 200 pharmaceuticals.
The main goal of the company is to “continue to offer modern and excellent products at reasonable prices by developing its product portfolio.” Szijjártó noted that Richter is “one of the most significant, successful and innovative pharmaceutical industry companies in Europe and our ‘regional multinational.’”
In 2017, the Hungarian Innovation Foundation awarded Richter the Innovation Grand Prize for the development of the drug cariprazine. In 2019, the Hungarian Society for Experimental and Clinical Pharmacology presented Richter with the Medicine of the Year award for Reagila, an atypical antipsychotic containing the active ingredient cariprazine.
FM Szijjártó said, “In Hungary, the pharmaceutical industry boasts a long tradition, and the country plays an outstanding role in the world’s pharmaceuticals production; accordingly, the pharmaceutical industry also plays an outstanding role in the performance of the Hungarian economy.” He noted that the pharmaceutical industry is one of the breakout sectors in Hungary, and the government will continue to do all it can to ensure that it remains a world leader in pharmaceutical production.
Chairman Erik Bogsch highlighted: “This inauguration ceremony represents another important step in our aspiration to provide a competitive and inspiring environment for our highly skilled staff, with which we are able to keep both talented fresh graduates and experienced professionals in Hungary.” Richter currently has 13,000 employees around the world.
Back in April, in response to the extraordinary situation caused by the coronavirus, Richter provided financial support to Italian pandemic hospitals via its local subsidiary in Milan, to Poland’s Western Hospital in Grodzisk Mazowiecki, and to various healthcare facilities in Romania as well. The company also supported Hungarian hospitals with a total donation of HUF 140 million. Each hospital and clinic that participated in its Health City Program received HUF 2 million of financial aid.